Physician

Adele Haimovic, M.D.

According to 2025 Medicare claims, Adele Haimovic, M.D. (NPI: 1518227800) practices dermatology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is DERMATOLOGY AND LASER CENTER PA (NPI: 1780894428; TIN: 223389267) and primary practice location at 07724-1888.

Haimovic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 918 HCPCS/CPT codes, and received $66,423 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 289 prescription claims across 137 beneficiaries totaling $126,643 in drug costs, led by Ketoconazole (Ketoconazole). Open Payments data shows 29 records totaling $488. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $292,121 to $126,643. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$42K$85K2017 Medicare payment: $28,250 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $73,763 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $69,278 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $63,417 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $70,909 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $84,723 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $83,858 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $66,423 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
201756188$28,250
2018125529$73,763
2019112598$69,278
2020108729$63,417
2021136722$70,909
2022153959$84,723
20232351,105$83,858
2024208918$66,423

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$146K$292K2015 Drug cost: $292,121 (USD; Tot_Drug_Cst)2016 Drug cost: $44,128 (USD; Tot_Drug_Cst)2017 Drug cost: $4,360 (USD; Tot_Drug_Cst)2018 Drug cost: $7,435 (USD; Tot_Drug_Cst)2019 Drug cost: $13,442 (USD; Tot_Drug_Cst)2020 Drug cost: $18,154 (USD; Tot_Drug_Cst)2021 Drug cost: $10,734 (USD; Tot_Drug_Cst)2022 Drug cost: $10,782 (USD; Tot_Drug_Cst)2023 Drug cost: $20,362 (USD; Tot_Drug_Cst)2024 Drug cost: $126,643 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201592250$292,121
20163154$44,128
20174364$4,360
201897229$7,435
201986227$13,442
202077230$18,154
202192226$10,734
2022100229$10,782
2023131284$20,362
2024137289$126,643

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth83106$79
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more5757$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more143234$70
17000Destruction of precancer skin growth, 1 growth69102$43
17003Destruction of precancer skin growth, 2-14 growths37197$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KetoconazoleKetoconazole361,126$661
Clobetasol PropionateClobetasol Propionate22695$638
Triamcinolone AcetonideTriamcinolone Acetonide501,349$497
MupirocinMupirocin541,131$472
HydrocortisoneHydrocortisone19373$127

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$488E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adele Haimovic, M.D.?

Tedicare shows public-source Medicare data for Adele Haimovic, M.D. (NPI 1518227800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adele Haimovic, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adele Haimovic, M.D.?

Adele Haimovic, M.D. is linked to DERMATOLOGY AND LASER CENTER PA (billing NPI 1780894428) in the available physician profile data.

Does Adele Haimovic, M.D. have Open Payments data?

Adele Haimovic, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.